News archive
Media Release
Aug 17, 2023
Siegfried delivers strong sales growth and profitability in first half 2023
Read more
Media Release
May 04, 2023
Siegfried acquires majority stake in DINAMIQS to establish a best-in-class development and manufacturing organization for cell and gene therapies
Read more
Media Release
Apr 25, 2023
Siegfried begins construction of a new global R&D Center for Drug Substances in Evionnaz
Read more
Media Release
Apr 20, 2023
Siegfried increases distribution and appoints new board member
Read more
Media Release
Mar 09, 2023
